What is ADXS stock price today?

Visit our real-time dashboard for the current ADXS stock price and live market data.

Is ADXS stock going up or down today?

ADXS stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy ADXS stock now?

The decision to buy ADXS depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is ADXS a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for ADXS based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is ADXS stock overvalued or undervalued?

Use our DCF valuation calculator to determine if ADXS is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is ADXS's P/E ratio?

P/E ratio data for ADXS will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is ADXS's market cap?

ADXS (Ayala Pharmaceuticals Inc. ) has a market capitalization of $0.00 billion, making it a small-cap stock.

What is ADXS's price to book ratio?

Price-to-book ratio for ADXS is available on our dashboard along with other valuation metrics.

Does ADXS pay dividends?

ADXS does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is ADXS's dividend yield?

ADXS does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is ADXS stock a good long-term investment?

ADXS's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is ADXS's revenue growth rate?

Revenue growth data for ADXS is available on our dashboard with detailed financial statement analysis.

Profitability metrics for ADXS are available on our dashboard with complete income statement analysis.

What are the risks of investing in ADXS?

Key risks for ADXS include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does ADXS compare to its competitors?

Compare ADXS to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize ADXS's performance and positioning.

What is ADXS's stock price target for 2026?

Visit our prediction page for AI-powered price targets for ADXS with bull, base, and bear case scenarios.

What do analysts say about ADXS?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for ADXS. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is ADXS's next earnings report?

ADXS reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

ADXS - Ayala Pharmaceuticals Inc.

NYSE * Healthcare * Biotechnology

$0.00

+$0.00 (+0.00%)

About Ayala Pharmaceuticals Inc.

Ayala Pharmaceuticals Inc. (ADXS) common stock

Price Chart

Loading chart...

ADXS Key Statistics

Market Cap

$1.71M

How ADXS Compares to Peers

ADXS is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 0

Growth Rank

N/A

of 0

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
ADXS(This stock)	$1.71M	N/A	0%	0.0%	-
AMGNAmgen Inc	$188.67B	24.3	0%	0.0%	vs AMGN
GILDGilead Sciences	$160.15B	17.5	0%	0.0%	vs GILD
VRTXVertex Pharmaceuticals	$106.87B	29.7	0%	0.0%	vs VRTX
REGNRegeneron Pharmaceuticals	$59.10B	13.9	0%	0.0%	vs REGN
BIIBBiogen Inc	$29.33B	21.4	0%	0.0%	vs BIIB

Data Updated: July 27, 2026 at 11:41 AM EDT

Ready to invest in ADXS?

Commission-free trading available. Affiliate links.

ADXS Lician Score

10% confidence

5.0/10

Neutral

ADXS has a Lician Score of 5/10 (Average). Areas of concern: Growth.

value

5.0

growth

3.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates ADXSacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

ADXS Financial Snowflake

5-axis analysis across key investment dimensions

4.6/10

Neutral

5.0

Value

Valuation vs. sector peers

3.0

Growth

Revenue & earnings trajectory

5.0

Quality

Profitability & moat strength

5.0

Momentum

Price trends & analyst sentiment

5.0

Safety

Financial stability & risk

Upcoming Events for ADXS

Dashboard

Enter a ticker to analyze